NEW YORK – A new study of the immune landscape of COVID-19 has found that type I interferons (IFN) exacerbate inflammation in severe cases of the disease.
NEW YORK – A new study of the immune landscape of COVID-19 has found that type I interferons (IFN) exacerbate inflammation in severe cases of the disease.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.